APO RESEARCH · REPORT
Anti-Peptic Ulcer Drugs
Anti-peptic Ulcre drug is one of various classes of drugs with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract.
Product & engineering
Understand the product.
Anti-peptic Ulcre drug is one of various classes of drugs with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract.
Selected research
Industry Growth & Trends
Global Anti-Peptic Ulcer Drugs Industry Growth and Trends Forecast to 2032
Market perspective
Anti-peptic Ulcre drug is one of various classes of drugs with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract.
According to APO Research, the global Anti-Peptic Ulcer Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
Report Scope
Read the full market overview
This report provides a structured, data-driven view of the global Anti-Peptic Ulcer Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Anti-Peptic Ulcer Drugs market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Anti-Peptic Ulcer Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Anti-Peptic Ulcer Drugs.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Anti-Peptic Ulcer Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Anti-Peptic Ulcer Drugs Market by Company
AstraZeneca
Ask-pharm
Takeda
Yangtze River Pharm
Shandong Luoxin
Huadong Medicine
Changzhou Siyao
Beijing Yuekang
Guangdong Dahua
Xian Janssen
Anti-Peptic Ulcer Drugs Segment by Type
Proton Pump Inhibitors (PPIs)
Potassium-Competitive Acid Blockers (P-CAB)
Antacids
H2 Antagonists
Ulcer Protective Drugs
Anti-Peptic Ulcer Drugs Segment by Application
Gastritis
Gastric Ulcers
Duodenal Ulcers
Gastroesophageal Reflux Disease (GERD)
Anti-Peptic Ulcer Drugs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-Peptic Ulcer Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Anti-Peptic Ulcer Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-Peptic Ulcer Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Anti-Peptic Ulcer Drugs companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Proton Pump Inhibitors (PPIs)
- Potassium-Competitive Acid Blockers (P-CAB)
- Antacids
- H2 Antagonists
- Ulcer Protective Drugs
Applications
- Gastritis
- Gastric Ulcers
- Duodenal Ulcers
- Gastroesophageal Reflux Disease (GERD)
Companies covered
- AstraZeneca
- Ask-pharm
- Takeda
- Yangtze River Pharm
- Shandong Luoxin
- Huadong Medicine
- Changzhou Siyao
- Beijing Yuekang
- Guangdong Dahua
- Xian Janssen
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Anti-Peptic Ulcer Drugs Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Anti-Peptic Ulcer Drugs Market Size by Region (2021-2032)
- 1.4.1 Global Anti-Peptic Ulcer Drugs Market Size by Region (2021-2026)
- 1.4.2 Global Anti-Peptic Ulcer Drugs Market Size by Region (2027-2032)
- 1.5 Key Regions Anti-Peptic Ulcer Drugs Market Size (2021-2032)
- 1.5.1 North America Anti-Peptic Ulcer Drugs Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Anti-Peptic Ulcer Drugs Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Anti-Peptic Ulcer Drugs Market Size Growth Rate (2021-2032)
- 1.5.4 South America Anti-Peptic Ulcer Drugs Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Anti-Peptic Ulcer Drugs Market Size Growth Rate (2021-2032)
2 Anti-Peptic Ulcer Drugs Market by Type
- 2.1 Type Introduction
- 2.1.1 Proton Pump Inhibitors (PPIs)
- 2.1.2 Potassium-Competitive Acid Blockers (P-CAB)
- 2.1.3 Antacids
- 2.1.4 H2 Antagonists
- 2.1.5 Ulcer Protective Drugs
- 2.2 Global Anti-Peptic Ulcer Drugs Market Size by Type
- 2.2.1 Global Anti-Peptic Ulcer Drugs Market Size Overview by Type (2021-2032)
- 2.2.2 Global Anti-Peptic Ulcer Drugs Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Anti-Peptic Ulcer Drugs Market Size Forecasted by Type (2027-2032)
- 2.3 Global Anti-Peptic Ulcer Drugs Market Size by Regions
- 2.3.1 North America Anti-Peptic Ulcer Drugs Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Anti-Peptic Ulcer Drugs Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Anti-Peptic Ulcer Drugs Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Anti-Peptic Ulcer Drugs Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Anti-Peptic Ulcer Drugs Market Size Breakdown by Type (2021-2026)
3 Anti-Peptic Ulcer Drugs Market by Application
- 3.1 Type Introduction
- 3.1.1 Gastritis
- 3.1.2 Gastric Ulcers
- 3.1.3 Duodenal Ulcers
- 3.1.4 Gastroesophageal Reflux Disease (GERD)
- 3.2 Global Anti-Peptic Ulcer Drugs Market Size by Application
- 3.2.1 Global Anti-Peptic Ulcer Drugs Market Size Overview by Application (2021-2032)
- 3.2.2 Global Anti-Peptic Ulcer Drugs Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Anti-Peptic Ulcer Drugs Market Size Forecasted by Application (2027-2032)
- 3.3 Global Anti-Peptic Ulcer Drugs Market Size by Regions
- 3.3.1 North America Anti-Peptic Ulcer Drugs Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Anti-Peptic Ulcer Drugs Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Anti-Peptic Ulcer Drugs Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Anti-Peptic Ulcer Drugs Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Anti-Peptic Ulcer Drugs Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Anti-Peptic Ulcer Drugs Industry Trends
- 4.2 Anti-Peptic Ulcer Drugs Industry Drivers
- 4.3 Anti-Peptic Ulcer Drugs Industry Opportunities and Challenges
- 4.4 Anti-Peptic Ulcer Drugs Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Anti-Peptic Ulcer Drugs Revenue (2021-2026)
- 5.2 Global Anti-Peptic Ulcer Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Anti-Peptic Ulcer Drugs Key Company Headquarters & Area Served
- 5.4 Global Anti-Peptic Ulcer Drugs Company, Product Type & Application
- 5.5 Global Anti-Peptic Ulcer Drugs Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Anti-Peptic Ulcer Drugs Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Anti-Peptic Ulcer Drugs Players Market Share by Revenue in 2025
- 5.6.3 2025 Anti-Peptic Ulcer Drugs Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 AstraZeneca
- 6.1.1 AstraZeneca Company Information
- 6.1.2 AstraZeneca Business Overview
- 6.1.3 AstraZeneca Anti-Peptic Ulcer Drugs Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 AstraZeneca Anti-Peptic Ulcer Drugs Product Portfolio
- 6.1.5 AstraZeneca Recent Developments
- 6.2 Ask-pharm
- 6.2.1 Ask-pharm Company Information
- 6.2.2 Ask-pharm Business Overview
- 6.2.3 Ask-pharm Anti-Peptic Ulcer Drugs Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Ask-pharm Anti-Peptic Ulcer Drugs Product Portfolio
- 6.2.5 Ask-pharm Recent Developments
- 6.3 Takeda
- 6.3.1 Takeda Company Information
- 6.3.2 Takeda Business Overview
- 6.3.3 Takeda Anti-Peptic Ulcer Drugs Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Takeda Anti-Peptic Ulcer Drugs Product Portfolio
- 6.3.5 Takeda Recent Developments
- 6.4 Yangtze River Pharm
- 6.4.1 Yangtze River Pharm Company Information
- 6.4.2 Yangtze River Pharm Business Overview
- 6.4.3 Yangtze River Pharm Anti-Peptic Ulcer Drugs Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Yangtze River Pharm Anti-Peptic Ulcer Drugs Product Portfolio
- 6.4.5 Yangtze River Pharm Recent Developments
- 6.5 Shandong Luoxin
- 6.5.1 Shandong Luoxin Company Information
- 6.5.2 Shandong Luoxin Business Overview
- 6.5.3 Shandong Luoxin Anti-Peptic Ulcer Drugs Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Shandong Luoxin Anti-Peptic Ulcer Drugs Product Portfolio
- 6.5.5 Shandong Luoxin Recent Developments
- 6.6 Huadong Medicine
- 6.6.1 Huadong Medicine Company Information
- 6.6.2 Huadong Medicine Business Overview
- 6.6.3 Huadong Medicine Anti-Peptic Ulcer Drugs Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Huadong Medicine Anti-Peptic Ulcer Drugs Product Portfolio
- 6.6.5 Huadong Medicine Recent Developments
- 6.7 Changzhou Siyao
- 6.7.1 Changzhou Siyao Company Information
- 6.7.2 Changzhou Siyao Business Overview
- 6.7.3 Changzhou Siyao Anti-Peptic Ulcer Drugs Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Changzhou Siyao Anti-Peptic Ulcer Drugs Product Portfolio
- 6.7.5 Changzhou Siyao Recent Developments
- 6.8 Beijing Yuekang
- 6.8.1 Beijing Yuekang Company Information
- 6.8.2 Beijing Yuekang Business Overview
- 6.8.3 Beijing Yuekang Anti-Peptic Ulcer Drugs Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Beijing Yuekang Anti-Peptic Ulcer Drugs Product Portfolio
- 6.8.5 Beijing Yuekang Recent Developments
- 6.9 Guangdong Dahua
- 6.9.1 Guangdong Dahua Company Information
- 6.9.2 Guangdong Dahua Business Overview
- 6.9.3 Guangdong Dahua Anti-Peptic Ulcer Drugs Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Guangdong Dahua Anti-Peptic Ulcer Drugs Product Portfolio
- 6.9.5 Guangdong Dahua Recent Developments
- 6.10 Xian Janssen
- 6.10.1 Xian Janssen Company Information
- 6.10.2 Xian Janssen Business Overview
- 6.10.3 Xian Janssen Anti-Peptic Ulcer Drugs Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Xian Janssen Anti-Peptic Ulcer Drugs Product Portfolio
- 6.10.5 Xian Janssen Recent Developments
7 North America
- 7.1 North America Anti-Peptic Ulcer Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Anti-Peptic Ulcer Drugs Market Size by Country (2021-2026)
- 7.3 North America Anti-Peptic Ulcer Drugs Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Anti-Peptic Ulcer Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Anti-Peptic Ulcer Drugs Market Size by Country (2021-2026)
- 8.3 Europe Anti-Peptic Ulcer Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Anti-Peptic Ulcer Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Anti-Peptic Ulcer Drugs Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Anti-Peptic Ulcer Drugs Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Anti-Peptic Ulcer Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Anti-Peptic Ulcer Drugs Market Size by Country (2021-2026)
- 10.3 South America Anti-Peptic Ulcer Drugs Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Anti-Peptic Ulcer Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Anti-Peptic Ulcer Drugs Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Anti-Peptic Ulcer Drugs Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst